Effect of Inflammation on Pharmacokinetics of Posaconazole

• Status: Completed
• Trial end date: 2017-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Posaconazole plasma concentration and inflammatory markers will be determined in all samples available from routine analysis.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Medical Center Groningen
• Treatments: Posaconazole

Criteria

Inclusion Criteria:

• >18 yrs

• receiving posaconazole

• Written informed consent

Exclusion Criteria:

• none